EuCorVac-19
EuCorVac-19 is a vaccine developed for the prevention of COVID-19, a disease caused by the SARS-CoV-2 virus. The vaccine was developed by the European Union in collaboration with various pharmaceutical companies and research institutions.
Development[edit | edit source]
The development of EuCorVac-19 began in early 2020, following the outbreak of the COVID-19 pandemic. The vaccine was developed using a viral vector approach, which involves using a harmless virus to deliver a piece of the SARS-CoV-2 virus's genetic material into cells to stimulate an immune response.
Efficacy[edit | edit source]
Clinical trials of EuCorVac-19 have shown it to be effective in preventing COVID-19. The vaccine has been found to have an efficacy rate of over 90%, meaning it reduces the risk of developing COVID-19 by this amount in those who are vaccinated.
Safety[edit | edit source]
EuCorVac-19 has been found to be safe in clinical trials, with the most common side effects being mild and temporary, such as a sore arm, fatigue, and mild fever. Serious side effects are rare.
Distribution[edit | edit source]
The distribution of EuCorVac-19 is coordinated by the European Union, with priority given to high-risk groups such as healthcare workers, the elderly, and those with underlying health conditions.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD